Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $0.0748 $0.0748 Friday, 10th May 2024 BLCM stock ended at $0.0748. During the day the stock fluctuated 0% from a day low at $0.0748 to a day high of $0.0748.
90 days $0.0701 $0.104
52 weeks $0.0600 $0.85

Historical Bellicum Pharmaceuticals prices

Date Open High Low Close Volume
Aug 11, 2016 $19.49 $19.68 $19.00 $19.60 190 600
Aug 10, 2016 $19.86 $19.86 $19.08 $19.21 268 800
Aug 09, 2016 $18.50 $19.99 $17.85 $19.88 758 900
Aug 08, 2016 $17.50 $17.80 $16.86 $17.05 337 200
Aug 05, 2016 $16.22 $17.93 $16.22 $17.36 425 300
Aug 04, 2016 $16.32 $16.60 $16.02 $16.17 263 200
Aug 03, 2016 $15.83 $16.29 $15.56 $16.14 261 900
Aug 02, 2016 $15.97 $16.24 $15.56 $15.88 319 600
Aug 01, 2016 $15.88 $16.60 $15.68 $16.04 448 800
Jul 29, 2016 $15.64 $16.04 $15.42 $15.88 255 700
Jul 28, 2016 $16.48 $16.60 $15.55 $15.75 258 600
Jul 27, 2016 $14.95 $16.49 $14.95 $16.38 534 300
Jul 26, 2016 $14.50 $14.98 $14.50 $14.86 386 500
Jul 25, 2016 $13.93 $14.67 $13.93 $14.51 289 300
Jul 22, 2016 $13.79 $14.12 $13.67 $13.86 167 800
Jul 21, 2016 $14.00 $14.40 $13.60 $13.76 231 800
Jul 20, 2016 $13.33 $14.23 $13.25 $13.84 379 700
Jul 19, 2016 $14.00 $14.15 $13.26 $13.30 229 300
Jul 18, 2016 $13.80 $14.25 $13.66 $14.06 253 800
Jul 15, 2016 $13.53 $13.89 $13.51 $13.78 274 800
Jul 14, 2016 $13.78 $13.93 $13.45 $13.50 417 800
Jul 13, 2016 $14.82 $14.90 $13.59 $13.65 404 100
Jul 12, 2016 $14.39 $14.79 $14.23 $14.53 243 700
Jul 11, 2016 $15.11 $15.42 $14.05 $14.23 485 300
Jul 08, 2016 $14.72 $15.47 $14.69 $14.96 768 300
Click to get the best stock tips daily for free!

About Bellicum Pharmaceuticals

Bellicum Pharmaceuticals Bellicum Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel cellular immunotherapies for the treatment of hematological cancers and solid tumors in the United States and internationally. The company's clinical product candidates include BPX-601, an autologous GoCAR-T product candidate, which is in Phase 1/2 clinical trials for the treatment of solid tumors expressing the prostate stem ce... BLCM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT